This compound is primarily utilized in the field of medicinal chemistry, particularly in the development of targeted cancer therapies. It functions as a key component in the design of proteolysis-targeting chimeras (PROTACs), which are innovative molecules used to degrade specific disease-causing proteins. By leveraging its structure, it helps in the selective degradation of oncogenic proteins, offering a promising approach for treating various cancers. Additionally, its application extends to research in understanding protein-protein interactions and cellular signaling pathways, contributing to advancements in drug discovery and therapeutic strategies.